Dry Powder Inhalers

Catalent invests $20m

Catalent inhales $20m investment

Catalent will invest $20m to upgrade its US pressurized Metered Dose Inhaler (pMDI) capabilities as part of a wider expansion of its inhaler business.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers